IBM stock tests key support despite $1 billion boost for quantum manufacturing
IBM is once again at a point where a single strong move could quickly reshape the short-term picture. With the market still hesitating, the next move from buyers becomes especially important.
253.18
256.00
IBM announced that its subsidiary Anderon has signed a $1 billion CHIPS and Science Act grant deal with the U.S. Department of Commerce. The company will utilize these funds for U.S.-based R&D and the scaling of quantum wafer manufacturing in the US at its Albany site and will also put in another $1 billion into Anderon.
The agreement effectively creates the first dedicated pure-play quantum foundry in the U.S., although the commercialization of quantum computing remains at an early stage.
$235–242 range becomes the key short-term test
IBM fully played out the scenario outlined earlier. The stock reached the $252 target but failed to extend the move and subsequently fell below $242 support.
For today’s session, the expected trading range is between $235, where the 50-day SMA is located, and $242. A break of either boundary is likely to determine the next short-term direction.
A recovery and sustained move above $242 would reopen the possibility of another test of $252. This remains the base-case scenario over the next several days.
A drop and sustained move below the 50-day SMA near $235 would invalidate the setup. In that case, the stock could extend the correction toward the next support around $230.
Long-term quantum progress meets short-term market pressure
The Anderon agreement strengthens IBM’s long-term position in quantum computing and reduces part of the financial burden associated with expanding manufacturing infrastructure. The market reaction, however, suggests that a long-term technology catalyst alone is not yet enough to generate a sustained recovery in the stock.
Over the next several sessions, the balance will depend primarily on whether buyers can reclaim $242. Until that happens, the positive developments around IBM’s quantum business are likely to remain more of a medium-term factor than an immediate price catalyst.
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
